TNF binding protein prevents hyperlactatemia and inactivation of PDH complex in skeletal muscle during sepsis

Journal of Surgical Research

Volumn 80, Issue 1, 1998, Pages 44-51

  Vary, Thomas C ^a   Hazen, Stacy A ^a   Maish III, George ^a   Cooney, Robert N ^a  

^a NONE

Author keywords

Hyperlactatemia; Lactate; Mitochondria; Pyruvate dehydrogenase complex; Pyruvate dehydrogenase kinase; Sepsis; Skeletal muscle

Indexed keywords

BINDING PROTEIN; PYRUVATE DEHYDROGENASE COMPLEX; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE METABOLISM; COMPLEX FORMATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME INACTIVATION; GLYCOLYSIS; HYPERLACTATEMIA; IMMUNE RESPONSE; METABOLIC REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS; SKELETAL MUSCLE;

EID: 0031766251     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5324     Document Type: Article

References (48)

1. Cerra F. B. Hypermetabolism-organ failure syndrome: A metabolic response to injury. Crit. Care Clin. 5:1989;289.
2. Vary T. C., Siegel J. H. Sepsis, abnormal metabolic control and the multiple organ failure syndrome. Trauma: Emergency Surgery and Critical Care. 1987;Churchill Livingstone, New York. p. 411-502.
3. Vary T. C., Siegel J. H., Rivikind A. Clinical and therapeutic significance of metabolic patterns of lactic acidosis. Perspect. Crit. Care. 1:1988;85.
4. Siegel J. H., Rivikind A. I., Dalal S., Goodari S. Early physiologic predictors of injury and death in blunt multiple trauma. Arch. Surg. 125:1990;498.
5. Cerra F. B. Metabolic manifestations of multiple organ failure. Crit. Care Clin. 5:1989;119.
6. Dantzker D. Oxygen delivery and utilization in sepsis. Crit. Care Clin. 5:1989;81.
7. Fish R. E., Lang C. H., Spitzer J. A. Regional blood flow during continuous low-dose endotoxin infusion. Circ. Shock. 18:1986;267.
8. Vary T. C., Siegel J. H., Nakatani T., Sato T., Aoyama H. Effect of sepsis on the activity of the pyruvate dehydrogenase complex in skeletal muscle and liver. Am. J. Physiol. 250:1986;E634.
9. Hotchkiss R. S., Karl I. E. Reevaluation of the role of extracellular hypoxia and bioenergenic failure in sepsis. JAMA. 267:1992;1503.
10. Wilmore D. W., Goodwin C. W., Aulick L. H., Powanda A. C., Mason A. D., Pruit B. A. Effect of injury and infection on visceral metabolism and circulation. Ann. Surg. 192:1980;491.
11. Dahn M. S., Lange P., Lobell K., Hans B., Jacobs L. A., Mitchell R. A. Splanchnic and total oxygen consumption differenecs in septic and injured patients. Surgery. 101:1987;69.
12. Vary T. C., Dardevet D., Obled C., Pouyet C., Breullie D., Grizard J. Modulation of skeletal muscle lactate metabolism following bacteremia by insulin or insulin-like growth factor-I: Effects of pentoxifylline. Shock. 7:1997;432.
13. Romanosky A. J., Bagby G. L., Bockman L., Spitzer J. J. Increased muscle glucose uptake and lactate release after endotoxin administration. Am. J. Physiol. 239:1981;E311.
14. Curtis S. E., Cain S. M. Regional and systemic oxygen delivery/uptake relations and lactate flux in hyperdynamic, endotoxin-treated dogs. Annu. Rev. Respir. Dis. 145:1992;348.
15. Bagby G. J., Lang C. H., Giamo M. E., Spitzer J. J. Increased glucose metabolism by epitrochlearis muscle removed from endotoxin-treated rats. Circ. Shock. 20:1986;171.
16. Vary T. C., Drnevich D., Jurasinski C., Brennan W. A. Mechanisms regulating skeletal muscle glucose metabolism in sepsis. Shock. 3:1995;403.
17. Lang C. H., Dobrescu C. Gram-negative infection increases non-insulin-mediated glucose dispersal. Endocrinology. 128:1991;645.
18. Meszaros K., Bagby G. J., Lang C. H., Spitzer J. J. Increased uptake and phosphorylation of 2-deoxyglucose by skeletal muscle in endotoxin-treated rats. Am. J. Physiol. 253:1987;E33.
19. Mela-Riker L., Bartos L. D., Vleiss A. A., Widener L., Muller P., Trunkey D. D. Chronic hyperdynamic sepsis in the rat II. Circ. Shock. 36:1992;83.
20. Brandi L. S., Santoro D., Natali A., Altomonte F., Baldi S., Frascerra S., Ferrannini E. Insulin resistance of stress: sites and mechanisms. Clin. Sci. 85:1993;525.
21. Vary T. C., Martin L. F. Potentiation of decreased pyruvate dehydrogenase activity by inflammatory stimuli in sepsis. Circ. Shock. 39:1993;299.
22. Vary T. C., Siegel J. H., Tall B. D., Morris J. G. Altered glucose regulation in sepsis revealed by partial reversal of PDH inhibition by dichloroacetate. Circ. Shock. 24:1988;3.
23. Vary T. C. Amrinone prevents the inhibition of muscle pyruvate dehydrogenase complex activity during sepsis. Shock. 5:1996;229.
24. Vary T. C. Sepsis-induced alterations in pyruvate dehydrogenase complex activity in rat skeletal muscle: Effects on plasma lactate. Shock. 6:1996;89.
25. Vary T. C. Increased pyruvate dehydrogenase kinase activity in response to sepsis. Am. J. Physiol. 250:1991;E669.
26. Cerra F. B., West M., Keller G., Mzuski J., Simmons R. L. Hypermetabolism/organ failure: Role of activated macrophage as a metabolic regulator. Prog. Clin. Biol. Med. 264:1988;27.
27. Tracey K. A. Tumor necrosis factor/cachetin in biology of the septic shock syndrome. Circ. Shock. 35:1991;123.
28. Hale K. K., Smith C. G., Baker S. L., Vanderslice R. W., Squires C. H., Gleason T. M., Tucker K. K., Kohno T., Russell D. A. Multifunctional regulation of the biological effects of TNF-α by soluble type I and type II TNF receptors. Cytokine. 7:1995;26.
29. Kohno T., Brewee M. T., Baker S. L., Schwartz P. E. A second tumor necrosis receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA. 78:1990;8331.
30. Cooney R. N., Kimball S. R., Vary T. C. Regulation of skeletal muscle protein turnover during sepsis: Mechanisms and mediators. Shock. 7:1997;1.
31. Vary T. C., Siegel J. H., Tall B. D., Morris J. G. Role of anaerobic bacteria in intra-abdominal septic abscesses in mediating septic control of skeletal muscle glucose oxidation and latic acidemia. J. Trauma. 29:1989;1003.
32. Nakatani T., Sato T., Marzella L., Hirai F., Trump B. F., Siegel J. H. Hepatic and systemic metabolic responses to aerobic and anaerobic intra-abdominal abscesses in a highly reproducible chronic rat model. Circ. Shock. 13:1984;271.
33. Russell D. A., Tucker K. K., Chinookoswong N., Thompson R., Kohno T. Combined inhibition of interleukin-1 and tumor necrosis factor in rodent endotoxemia: Improved survival and organ function. J. Infect. Dis. 171:1995;1528.
34. Espat N. J., Cendan J. C., Beirle E. A., Auffenberg T. A., Rosenberg J., Russell D. A., Kenney J. S., Fischer E., Montegut W., Lowry S. F., Copeland E. M. III, Moldawer L. L. PEG-BP-30 monotherapy attenuates the cytokine mediated inflammatory cascade in baboon Escherichia coli septic shock. J. Surg. Res. 50:1995;153.
35. Jurasinski C., Kilpatrick L., Vary T. C. Amrinone prevents muscle wasting during chronic sepsis. Am. J. Physiol. 26:1995;E491.
36. Cooney R. N., Iocono J., Maish G. III, Smith J. S., Ehrlich P. Tumor necrosis factor mediates impaired wound healing in chronic abdominal sepsis. J. Trauma. 42:1997;415.
37. Fuller S. J., Randle P. J. Reversible phosphorylation of pyruvate dehydrogenase in rat skeletal muscle mitochondria: Effects of starvation and diabetes. Biochem. J. 219:1984;635.
38. Kerbey A. L., Randle P. J., Cooper R. H., Whitehouse S., Pask H. T., Denton R. M. Regulation of pyruvate dehydrogenase in rat heart. Biochem. J. 219:1976;635.
39. Kerbey A. L., Randle P. J. Pyruvate dehydrogenase kinase/activator in rat heart mitochondria. Biochem. J. 206:1982;103.
40. Fantania H. R., Vary T. C., Randle P. J. Modulation of PDH kinase activity in cultured hepatocytes by glucagon and n-octanoate. Biochem. J. 234:1986;235.
41. Coore H. G., Denton R. M., Martin B. R., Randle P. J. Regulation of adipose tissue pyruvate dehydrogenase by insulin and other hormones. Biochem. J. 125:1971;117.
42. Vary T. C., Murphy J. M. Role of extra-splanchnic organs in the metabolic response to sepsis: Effect of insulin. Circ. Shock. 29:1989;41.
43. Lang C. H., Cooney R. N., Vary T. C. Central interleukin-1 partially mediates endotoxin-induced changes in glucose metabolism. Am J. Physiol. 271:1996;E309.
44. Breuille D. M., Farge M. C., Rose R., Arnal M., Obled C. Pentoxyfylline decreases the body weight loss and muscle protein wasting characteristic of sepsis. Am. J. Physiol. 265:1993;E660.
45. Petit F., Bagby G. J., Lang C. H. Tumor necrosis factor mediates zymogen-induced increase in glucose flux and insulin resistance. Am. J. Physiol. 268:1995;E219.
46. Bagby G. J., Lang C. H., Skrepnik N., Golightly G., Spitzer J. J. Regulation of glucose metabolism after endotoxin and during infection is largely independent of endogenous tumor necrosis factor. Circ. Shock. 39:1993;211.
47. Doherty G. M., Jensen J. C., Alexander H. R., Buresh C. M., Norton J. A. Pentoxifylline supression of tumor necrosis factor gene transcription. Surgery. 111:1991;192.
48. Giroir B. P., Beutler B. Effect of amrinone on tumor necrosis factor production in endotoxin shock. Circ. Shock. 36:1992;200.